NMES + High Protein for Brain Hemorrhage Recovery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if combining early muscle stimulation (NMES, or Neuromuscular Electrical Stimulation) and high-protein supplements can improve recovery in individuals with brain hemorrhages, specifically aneurysmal subarachnoid hemorrhage (SAH). Researchers seek to discover whether these treatments enhance muscle health and reduce inflammation compared to standard care. Participants will be divided into groups to receive NMES, high protein, both, or standard care, allowing measurement of the impact on muscle strength and recovery. This trial suits adults diagnosed with aneurysmal SAH who have undergone repair within 48 hours and are expected to remain in intensive care for more than 72 hours. As an unphased trial, it offers a unique opportunity to contribute to pioneering research that could enhance recovery strategies for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that neuromuscular electrical stimulation (NMES) is safe and effective for early rehabilitation. It prevents muscle loss and strengthens muscles in critically ill patients. Studies have found that NMES is easy to tolerate and can reduce pain and stiffness, making it a valuable recovery tool.
High protein supplementation (HPRO) is also generally safe and beneficial for recovery after a brain hemorrhage. A high-protein diet helps maintain muscle strength and improve overall health. Combining HPRO with NMES may further enhance recovery by reducing muscle loss and improving function.
Overall, both NMES and HPRO have been shown to be safe, with studies supporting their use in similar health conditions. Participants can feel reassured that these treatments are well-tolerated and may aid in their recovery process.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the NMES + High Protein treatments for brain hemorrhage recovery because they combine electrical muscle stimulation with high protein supplementation, potentially enhancing muscle recovery and nutritional status simultaneously. Unlike standard treatments that rely primarily on standard rehabilitation and nutrition, NMES specifically targets muscle activation through electrical impulses, while high protein intake supports muscle repair and growth. This dual approach might accelerate recovery by not only improving physical function but also optimizing the body's protein needs, offering a potentially more effective path to rehabilitation for patients.
What evidence suggests that NMES and high protein supplementation could be effective for brain hemorrhage recovery?
Research has shown that neuromuscular electrical stimulation (NMES), one of the treatments in this trial, can aid recovery and improve daily activity performance after a stroke. One study found that NMES was more effective at preventing muscle loss than standard treatments. High protein supplements (HPRO), another treatment option in this trial, have been shown to help maintain muscle strength after a brain bleed and may enhance recovery. This trial will also test the combination of HPRO and NMES, which might help maintain muscle and prevent muscle loss after a specific type of brain bleed called subarachnoid hemorrhage (SAH). Early results suggest that this combination can also positively impact inflammation and energy levels, which are important for recovery.23678
Who Is on the Research Team?
Neeraj Badjatia, MD
Principal Investigator
University of Maryland, Baltimore
Are You a Good Fit for This Trial?
Adults aged 25-80 with recent aneurysmal subarachnoid hemorrhage (SAH), who've had aneurysm repair within 48 hours, and will stay in intensive care for over 72 hours. Participants should have a certain severity of SAH but not be too unwell or have conditions like severe kidney issues, muscle disorders, active cancer, or allergies to whey protein.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive NMES and/or HPRO interventions to improve muscle mass and metabolic profiles
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- High Protein Supplementation
- NMES
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor